ProfileGDS4718 / 208835_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 95% 97% 98% 95% 97% 97% 97% 95% 94% 93% 94% 98% 96% 97% 97% 94% 92% 97% 97% 99% 96% 96% 93% 95% 97% 96% 94% 99% 97% 98% 94% 96% 97% 93% 97% 97% 97% 97% 96% 97% 94% 98% 97% 98% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.465695
GSM549102patient 115, normal, homogenized [OPG study]11.048897
GSM549104patient 119, normal, homogenized [OPG study]11.61998
GSM549108patient 138, normal, homogenized [OPG study]10.26795
GSM549119patient 077, normal, homogenized [OPG study]11.246697
GSM549133patient 032, cancer, homogenized [OPG study]11.057897
GSM549139patient 042, cancer, homogenized [OPG study]10.861297
GSM549099patient 107, normal, homogenized [OPG study]10.205395
GSM549109patient 139, normal, homogenized [OPG study]10.093894
GSM549110patient 046, normal, homogenized [OPG study]9.9189993
GSM549114patient 063, normal, homogenized [OPG study]10.137494
GSM549122patient 082, normal, homogenized [OPG study]11.680198
GSM549134patient 033, cancer, homogenized [OPG study]10.503796
GSM549136patient 036, cancer, homogenized [OPG study]10.832197
GSM549140patient 044, cancer, homogenized [OPG study]10.728797
GSM549111patient 047, normal, homogenized [OPG study]10.039894
GSM549113patient 057, normal, homogenized [OPG study]9.8018292
GSM549132patient 031, cancer, homogenized [OPG study]10.718997
GSM549137patient 038, cancer, homogenized [OPG study]10.870497
GSM549142patient 047, cancer, homogenized [OPG study]12.814499
GSM549100patient 110, normal, homogenized [OPG study]10.619296
GSM549107patient 135, normal, homogenized [OPG study]10.568796
GSM549115patient 068, normal, homogenized [OPG study]10.073593
GSM549116patient 072, normal, homogenized [OPG study]10.334195
GSM549120patient 078, normal, homogenized [OPG study]11.045397
GSM549131patient 030, cancer, homogenized [OPG study]10.411696
GSM549118patient 074, normal, homogenized [OPG study]10.15594
GSM549129patient 027, cancer, homogenized [OPG study]12.063999
GSM549123patient 088, normal, homogenized [OPG study]10.867997
GSM549124patient 006, cancer, homogenized [OPG study]11.154298
GSM549126patient 015, cancer, homogenized [OPG study]9.8269994
GSM549128patient 025, cancer, homogenized [OPG study]10.627996
GSM549103patient 117, normal, homogenized [OPG study]11.010197
GSM549117patient 073, normal, homogenized [OPG study]9.8929193
GSM549138patient 041, cancer, homogenized [OPG study]11.104997
GSM549141patient 045, cancer, homogenized [OPG study]10.952197
GSM549130patient 028, cancer, homogenized [OPG study]10.821697
GSM549101patient 111, normal, homogenized [OPG study]10.70297
GSM549105patient 128, normal, homogenized [OPG study]10.631196
GSM549106patient 134, normal, homogenized [OPG study]11.181797
GSM549112patient 048, normal, homogenized [OPG study]10.105194
GSM549125patient 011, cancer, homogenized [OPG study]11.19798
GSM549127patient 024, cancer, homogenized [OPG study]10.674797
GSM549135patient 035, cancer, homogenized [OPG study]11.198498